Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn Sells 4,720 Shares

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 4,720 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total transaction of $128,903.20. Following the completion of the sale, the senior vice president now owns 110,309 shares in the company, valued at approximately $3,012,538.79. The trade was a 4.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Amy Beth Vanduyn also recently made the following trade(s):

• On Wednesday, January 15th, Amy Beth Vanduyn sold 604 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $16,295.92.
• On Monday, January 6th, Amy Beth Vanduyn sold 1,311 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $34,885.71.
• On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The shares were sold at an average price of $20.93, for a total value of $532,605.71.

Phreesia Stock Down 0.2 %

Shares of Phreesia stock opened at $27.29 on Thursday. The business has a 50-day moving average price of $23.77 and a two-hundred day moving average price of $22.94. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last released its earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter last year, the firm posted ($0.58) earnings per share. The firm’s revenue was up 16.6% on a year-over-year basis. As a group, sell-side analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have commented on PHR. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. KeyCorp boosted their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Needham & Company LLC restated a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Friday, January 10th. Robert W. Baird cut their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Finally, Truist Financial increased their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Phreesia currently has an average rating of “Buy” and an average price target of $31.00.

Institutional Trading of Phreesia

Several hedge funds have recently modified their holdings of PHR. International Assets Investment Management LLC grew its holdings in Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares during the period. Lombard Odier Asset Management USA Corp acquired a new stake in shares of Phreesia in the 2nd quarter valued at about $202,000. Point72 DIFC Ltd bought a new stake in Phreesia in the 2nd quarter valued at about $209,000. XTX Topco Ltd acquired a new position in Phreesia during the 3rd quarter worth approximately $247,000. Finally, Hsbc Holdings PLC bought a new position in Phreesia in the second quarter worth approximately $301,000. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.